Clinical Trial Update: Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on losartan and uric acid metabolism in children with proteinuric nephropathies; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uric Acid Nephropathy

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Hospital General de Niños Pedro de Elizalde | Conditions: Uric Acid Nephropathy | Phase 4 | Status: COMPLETED